相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rationally Designed Small Molecules Targeting the RNA That Causes Myotonic Dystrophy Type 1 Are Potently Bioactive
Jessica L. Childs-Disney et al.
ACS CHEMICAL BIOLOGY (2012)
Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins
Eric T. Wang et al.
CELL (2012)
Myotonic dystrophy: is a narrow focus obscuring the rest of the field?
Mani S. Mahadevan
CURRENT OPINION IN NEUROLOGY (2012)
Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of CaV1.1 calcium channel
Zhen Zhi Tang et al.
HUMAN MOLECULAR GENETICS (2012)
Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise
Christopher M. Chamberlain et al.
HUMAN MOLECULAR GENETICS (2012)
The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing
Aymeric Ravel-Chapuis et al.
JOURNAL OF CELL BIOLOGY (2012)
Design of a Bioactive Small Molecule That Targets the Myotonic Dystrophy Type 1 RNA via an RNA Motif-Ligand Database and Chemical Similarity Searching
Raman Parkesh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
Bjarne Udd et al.
LANCET NEUROLOGY (2012)
Targeting nuclear RNA for in vivo correction of myotonic dystrophy
Thurman M. Wheeler et al.
NATURE (2012)
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Ryszard Kole et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy
Konstantinos Charizanis et al.
NEURON (2012)
Muscleblind-Like 1 Knockout Mice Reveal Novel Splicing Defects in the Myotonic Dystrophy Brain
Koichi Suenaga et al.
PLOS ONE (2012)
RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1
Johanna E. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
RNA Foci, CUGBP1, and ZNF9 Are the Primary Targets of the Mutant CUG and CCUG Repeats Expanded in Myotonic Dystrophies Type 1 and Type 2
Karlie Jones et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Alternative splicing of PDLIM3/ALP, for α-actinin-associated LIM protein 3, is aberrant in persons with myotonic dystrophy
Natsumi Ohsawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1
Michinori Koebis et al.
GENES TO CELLS (2011)
Stabilization of Expanded (CTG)•(CAG) Repeats by Antisense Oligonucleotides
Masayuki Nakamori et al.
MOLECULAR THERAPY (2011)
Pip5 Transduction Peptides Direct High Efficiency Oligonucleotide-mediated Dystrophin Exon Skipping in Heart and Phenotypic Correction in mdx Mice
HaiFang Yin et al.
MOLECULAR THERAPY (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy
Charlotte Fugier et al.
NATURE MEDICINE (2011)
Targeting RNA to treat neuromuscular disease
Francesco Muntoni et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs
Virginie Francois et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
Non-ATG-initiated translation directed by microsatellite expansions
Tao Zu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models
Amparo Garcia-Lopez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Yimin Hua et al.
GENES & DEVELOPMENT (2010)
CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1
Amanda J. Ward et al.
HUMAN MOLECULAR GENETICS (2010)
Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1
Misha Koshelev et al.
HUMAN MOLECULAR GENETICS (2010)
Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
Kim N. Chi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
An Upstream Open Reading Frame and the Context of the Two AUG Codons Affect the Abundance of Mitochondrial and Nuclear RNase H1
Yutaka Suzuki et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2010)
Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy
Hongqing Du et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2
Y. G. Weber et al.
NEUROLOGY (2010)
PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1
Guey-Shin Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Rational Design of Ligands Targeting Triplet Repeating Transcripts That Cause RNA Dominant Disease: Application to Myotonic Muscular Dystrophy Type 1 and Spinocerebellar Ataxia Type 3
Alexei Pushechnikov et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Pentamidine reverses the splicing defects associated with myotonic dystrophy
M. Bryan Warf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
Susan A. M. Mulders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neutralizing Toxic RNA
Thomas A. Cooper
SCIENCE (2009)
Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
Thurman M. Wheeler et al.
SCIENCE (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy
James P. Orengo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart
Auinash Kalsotra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1
Shin-ichiro Hino et al.
HUMAN MOLECULAR GENETICS (2007)
Increased steady-state in levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation
N. Muge Kuyumcu-Martinez et al.
MOLECULAR CELL (2007)
Myotonic dystrophy: RNA-mediated muscle disease
Thurman M. Wheeler et al.
CURRENT OPINION IN NEUROLOGY (2007)
Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy
Guey-Shin Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1
John D. Lueck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Huntington's disease-like 2 is associated with CUG repeat-containing RNA foci
Dobrila D. Rudnicki et al.
ANNALS OF NEUROLOGY (2007)
Interaction of musleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing
Sharan Paul et al.
EMBO JOURNAL (2006)
Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy
Mani S. Mahadevan et al.
NATURE GENETICS (2006)
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy
Rahul N. Kanadia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy
Xiaoyan Lin et al.
HUMAN MOLECULAR GENETICS (2006)
Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF
DH Cho et al.
MOLECULAR CELL (2005)
Activation of the mammalian immune system by siRNAs
JT Marques et al.
NATURE BIOTECHNOLOGY (2005)
Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells
MA Langlois et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1
W Dansithong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence
DH Kim et al.
NUCLEIC ACIDS RESEARCH (2005)
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation
RJ Hagerman et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Structural requirements at the catalytic site of the heteroduplex substrate for human RNase H1 catalysis
WF Lima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Muscleblind proteins regulate alternative splicing
TH Ho et al.
EMBO JOURNAL (2004)
Myotonic dystrophy: RNA pathogenesis comes into focus
LPW Ranum et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
A muscleblind knockout model for myotonic dystrophy
RN Kanadia et al.
SCIENCE (2003)
Clinical features of boys with fragile X premutations and intermediate alleles
M Aziz et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes
G Stevanin et al.
BRAIN (2003)
Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts
MA Langlois et al.
MOLECULAR THERAPY (2003)
Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions
D Furling et al.
GENE THERAPY (2003)
Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2
A Mankodi et al.
ANNALS OF NEUROLOGY (2003)
Expanded CUG repeats trigger aberrant splicing of CIC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy
A Mankodi et al.
MOLECULAR CELL (2002)
Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing
N Charlet-B et al.
MOLECULAR CELL (2002)
Dominantly inherited, non-coding microsatellite expansion disorders
LPW Ranum et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2
A Mankodi et al.
HUMAN MOLECULAR GENETICS (2001)
Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
RS Savkur et al.
NATURE GENETICS (2001)
Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9
CL Liquori et al.
SCIENCE (2001)
RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1
NA Timchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10
T Matsuura et al.
NATURE GENETICS (2000)
Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat
A Mankodi et al.
SCIENCE (2000)
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
PS Sarkar et al.
NATURE GENETICS (2000)
Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy
TR Klesert et al.
NATURE GENETICS (2000)
Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy
JW Miller et al.
EMBO JOURNAL (2000)
分享论文
